Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026)
Assembly Biosciences (ASMB) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-16,666.00 |
| Dec 31, 2025 |
13,561.00 |
| Sep 30, 2025 |
2,273.00 |
| Jun 30, 2025 |
-1,215.00 |
| Mar 31, 2025 |
4,716.00 |
| Dec 31, 2024 |
-279.00 |
| Sep 30, 2024 |
-711.00 |
| Jun 30, 2024 |
2,831.00 |
| Mar 31, 2024 |
-931.00 |
| Dec 31, 2020 |
-380,152.00 |
| Sep 30, 2020 |
-2,938.00 |
| Jun 30, 2020 |
66,928.00 |
| Mar 31, 2020 |
-8,226.00 |
| Dec 31, 2019 |
2,311.00 |
| Sep 30, 2019 |
787.00 |
| Jun 30, 2019 |
9,448.00 |
| Mar 31, 2019 |
667.00 |
| Dec 31, 2018 |
-19,816.00 |
| Sep 30, 2018 |
32,825.00 |
| Jun 30, 2018 |
-37,263.00 |
